Cerebral infarct due to meningovascular neurobrucellosis: A case report

International Journal of Infectious Diseases

Volumn 14, Issue SUPPL. 3, 2010, Pages

  Ay, Saime ^a   Tur, Birkan Sonel ^b   Kutlay, Şehim ^b  

^a UFUK UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Neurobrucellosis; Stroke

Indexed keywords

COTRIMOXAZOLE; DOXYCYCLINE; RIFAMPICIN;

ADULT; ARTICLE; BACTERIUM CULTURE; BRAIN ANGIOGRAPHY; BRAIN INFARCTION; BRUCELLOSIS; CASE REPORT; CLINICAL FEATURE; FACIAL NERVE PARALYSIS; HEMIPARESIS; HUMAN; HYPESTHESIA; LABORATORY TEST; MALE; MENINGOVASCULAR NEUROBRUCELLOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; STENT;

ADULT; ANTI-BACTERIAL AGENTS; BRUCELLA MELITENSIS; BRUCELLOSIS; CENTRAL NERVOUS SYSTEM BACTERIAL INFECTIONS; CEREBRAL INFARCTION; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 77957326867     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.07.012     Document Type: Article

References (16)

1. Ozi{dotless}si{dotless}k H., Ersoy Y., Tevfik M.R. Isolated intracranial hypertension: a rare presentation of neurobrucellosis. Microbes Infect 2004, 6:861-863.
2. Abdolbagi M.H., Nejad M.R., Jafari S., Hasibi M., Soudbakhsh A. Clinical and laboratory findings in neurobrucellosis: review of 31 cases. Arch Iranian Med 2008, 11:21-25.
3. Bucher A., Gaustad P., Pape E. Chronic neurobrucellosis due to Brucella melitensis. Scand J Infect Dis 1990, 22:223-226.
4. Al Deeb S.M., Yaqub B.A., Sharif H.S., Phadke J.G. Neurobrucellosis: clinical characteristics, diagnosis, and outcome. Neurology 1989, 39:498-501.
5. McLean D.R., Russell N., Khan M.Y. Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis 1992, 15:582-590.
6. Adaletli I., Albayram S., Gurses B., Ozer H., Yi{dotless}lmaz M.H., Gulsen F., et al. Vasculopathic changes in the cerebral arterial system with neurobrucellosis. AJNR Am J Neuroradiol 2006, 27:384-386.
7. Bahemuka M., Shemena A.R., Panayiotopoulos C.P., al-Aska A.K., Obeid T., Daif A.K. Neurological syndromes of brucellosis. J Neurol Neurosurg Psychiatry 1988, 51:1017-1021.
8. Irmak H., Buzgan T., Evirgen O., Akdeniz H., Demiröz A.P., Abdoel T.H., et al. Use of the Brucella IgM and IgG flow assays in the serodiagnosis of human brucellosis in an area endemic for brucellosis. Am J Trop Med Hyg 2004, 70:688-694.
9. Martinez E., Munoz A., Esparza J., Munoz M.J., Giangaspro E. Focal cerebral involvement by neurobrucellosis: pathological and MRI findings. Eur J Radiol 2002, 43:28-30.
10. Gül H.C., Erdem H., Gorenek L., Ozdag M.F., Kalpakci{dotless} Y., Avci I.Y., et al. Management of neurobrucellosis: an assessment of 11 cases. Intern Med 2008, 47:995-1001.
11. Eren S., Bayam G., Ergönül O., Celikbaş A., Baykam N., Dokuzoĝuz B., et al. Cognitive and emotional changes in neurobrucellosis. J Infect 2006, 53:184-189.
12. Sausa A.S., Torres C., Campello M.G., Garcia C., Parras F., Cercenado E., et al. Serological diagnosis of neurobrucellosis. J Clin Pathol 1990, 43:79-81.
13. Cannat A., Escande A., Peraldi F., Sere A. Induction of autoantibodies and circulating immune complexes in mice after injection of Brucella fraction "PI" or inoculation with live Brucella suis. Ann Immunol 1983, 134:43-53.
14. Zaidan R., Al Tahan A.R. Cerebral venous thrombosis: a new manifestation of neurobrucellosis. Clin Infect Dis 1999, 28:399-400.
15. Shamelian S.O. Diagnosis and treatment of brucellosis. Neth J Med 2000, 56:198-200.
16. Ariza J., Gudiol F., Pallares R., Viladrich P.F., Rufi G., Corredoira J., Miravitlles M.R. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann Intern Med 1992, 117:25-30.